Patents by Inventor Beni B. Wolf

Beni B. Wolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS
    Publication number: 20160251445
    Abstract: Methods for optimizing a therapeutic response in a patient (e.g., a cancer patient) to an anti-EGFR therapy, and methods for preventing or ameliorating infusion reactions in a patient receiving an anti-EGFR therapy are disclosed.
    Type: Application
    Filed: May 17, 2016
    Publication date: September 1, 2016
    Inventors: Jeffrey David KEARNS, Beni B. WOLF
  • Diagnostic Assays and Kits for Detection of Folate Receptor 1
    Publication number: 20160146824
    Abstract: The invention generally relates to antibodies that bind to human folate receptor 1 and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
    Type: Application
    Filed: October 23, 2015
    Publication date: May 26, 2016
    Applicant: ImmunoGen, Inc.
    Inventors: Christina N. CARRIGAN, Olga AB, Daniel Tavares, Beni B. Wolf, Nathan E. Testa
  • DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS
    Publication number: 20160009822
    Abstract: Methods for optimizing a therapeutic response in a patient (e.g., a cancer patient) to an anti-EGFR therapy, and methods for preventing or ameliorating infusion reactions in a patient receiving an anti-EGFR therapy are disclosed.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 14, 2016
    Inventors: Jeffrey David KEARNS, Beni B. WOLF
  • Diagnostic assays and kits for detection of folate receptor 1
    Patent number: 9200073
    Abstract: The invention generally relates to antibodies that bind to human folate receptor 1 and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: December 1, 2015
    Assignee: ImmunoGen, Inc.
    Inventors: Christina N. Carrigan, Olga Ab, Daniel Tavares, Beni B. Wolf
  • DIAGNOSTIC ASSAYS AND KITS FOR DETECTION OF FOLATE RECEPTOR 1
    Publication number: 20140099332
    Abstract: The invention generally relates to antibodies that bind to human folate receptor 1 and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
    Type: Application
    Filed: August 30, 2013
    Publication date: April 10, 2014
    Inventors: NATHAN E. TESTA, CHRISTINA N. CARRIGAN, OLGA AB, DANIEL TAVARES, BENI B. WOLF
  • Compositions and Methods Relating to STOP-1
    Publication number: 20110112279
    Abstract: The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
    Type: Application
    Filed: July 28, 2010
    Publication date: May 12, 2011
    Applicant: Genentech, Inc.
    Inventors: HEIDI ACKERLY, Avi Ashkenazi, David Eberhard, Gretchen Frantz, Dorothy French, Germaine G. Fuh, Jo-Anne S. Hongo, Chingwei V. Lee, Scot A. Marsters, Helga A. Raab, Evgeny Varfolomeev, Beni B. Wolf, Robert Maurice Pitti, Liliana Soroceanu
  • Compositions and methods relating to STOP-1
    Patent number: 7799899
    Abstract: The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: September 21, 2010
    Assignee: Genentech, Inc.
    Inventors: Heidi Ackerly, Avi Ashkenazi, David Eberhard, Gretchen Frantz, Dorothy French, Germaine G. Fuh, Jo-Anne S. Hongo, Chingwei V. Lee, Scot A. Masters, Helga A. Raab, Evgeny Varfolomeev, Beni B. Wolf, Robert Maurice Pitti, Liliana Soroceanu
  • Fibroblast Activation Protein Inhibitor Compounds and Methods
    Publication number: 20080280856
    Abstract: Amino terminus-blocked peptide boronate compounds of Formulas I and II are useful for inhibiting Fibroblast Activation Protein (FAP) and other proteases, and for treating disorders mediated by FAP. Methods of using the amino terminus blocked peptide boronate compounds, and stereoisomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
    Type: Application
    Filed: June 4, 2008
    Publication date: November 13, 2008
    Applicant: Genentech, Inc.
    Inventors: Frederick Cohen, Wayne J. Fairbrother, Clifford Quan, Daniel P. Sutherlin, Beni B. Wolf
  • Fibroblast activation protein inhibitor compounds and methods
    Patent number: 7399869
    Abstract: Amino terminus-blocked peptide boronate compounds of Formulas I and II are useful for inhibiting Fibroblast Activation Protein (FAP) and other proteases, and for treating disorders mediated by FAP. Methods of using the amino terminus blocked peptide boronate compounds, and stereoisomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: July 15, 2008
    Assignee: Genentech, Inc.
    Inventors: Frederick Cohen, Wayne J. Fairbrother, Clifford Quan, Daniel P. Sutherlin, Beni B. Wolf
  • Compositions and Methods Relating to Stop-1
    Publication number: 20080050377
    Abstract: The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
    Type: Application
    Filed: April 16, 2004
    Publication date: February 28, 2008
    Applicant: GENENTECH, INC.
    Inventors: Heidi Ackerly, Avi Ashkenazi, David Eberhard, Gretchen Frantz, Dorothy French, Germaine G. Fuh, Jo-Anne S. Hongo, Chingwei V. Lee, Scot A. Marsters, Helga A. Raab, Evgeny Varfolomeev, Beni B. Wolf, Robert Maurice Pitti, Liliana Soroceanu